Cargando…

High Affinity Promotes Internalization of Engineered Antibodies Targeting FGFR1

Fibroblast growth factor receptor 1 (FGFR1) is a plasma membrane protein that transmits signals from the extracellular environment, regulating cell homeostasis and function. Dysregulation of FGFR1 leads to the development of human cancers and noncancerous diseases. Numerous tumors overproduce FGFR1,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Opaliński, Łukasz, Szymczyk, Jakub, Szczepara, Martyna, Kucińska, Marika, Krowarsch, Daniel, Zakrzewska, Małgorzata, Otlewski, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983756/ https://www.ncbi.nlm.nih.gov/pubmed/29748524 http://dx.doi.org/10.3390/ijms19051435

Ejemplares similares

Antibody-induced dimerization of FGFR1 promotes receptor endocytosis independently of its kinase activity
por: Opaliński, Łukasz, et al.
Publicado: (2017)

FHF1 is a bona fide fibroblast growth factor that activates cellular signaling in FGFR-dependent manner
por: Sochacka, Martyna, et al.
Publicado: (2020)

FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms
por: Szymczyk, Jakub, et al.
Publicado: (2022)

FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization
por: Pozniak, Marta, et al.
Publicado: (2020)

The cytotoxic conjugate of highly internalizing tetravalent antibody for targeting FGFR1-overproducing cancer cells
por: Poźniak, Marta, et al.
Publicado: (2021)

FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
por: Szymczyk, Jakub, et al.
Publicado: (2021)

FGF12 is a novel component of the nucleolar NOLC1/TCOF1 ribosome biogenesis complex
por: Sochacka, Martyna, et al.
Publicado: (2022)

Receptor clustering by a precise set of extracellular galectins initiates FGFR signaling
por: Zukowska, Dominika, et al.
Publicado: (2023)

Low Stability of Integrin-Binding Deficient Mutant of FGF1 Restricts Its Biological Activity
por: Szlachcic, Anna, et al.
Publicado: (2019)

Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment
por: Porębska, Natalia, et al.
Publicado: (2018)

Cross-Talk between Fibroblast Growth Factor Receptors and Other Cell Surface Proteins
por: Latko, Marta, et al.
Publicado: (2019)

Differential regulation of fibroblast growth factor receptor 1 trafficking and function by extracellular galectins
por: Kucińska, Marika, et al.
Publicado: (2019)

Intrinsically Fluorescent Oligomeric Cytotoxic Conjugates Toxic for FGFR1-Overproducing Cancers
por: Porębska, Natalia, et al.
Publicado: (2021)

Intracellular FGF1 protects cells from apoptosis through direct interaction with p53
por: Lampart, Agata, et al.
Publicado: (2023)

Increased Protein Stability of FGF1 Can Compensate for Its Reduced Affinity for Heparin
por: Zakrzewska, Malgorzata, et al.
Publicado: (2009)

Modular self-assembly system for development of oligomeric, highly internalizing and potent cytotoxic conjugates targeting fibroblast growth factor receptors
por: Poźniak, Marta, et al.
Publicado: (2021)

N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
por: Gregorczyk, Paulina, et al.
Publicado: (2023)

Galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling
por: Gedaj, Aleksandra, et al.
Publicado: (2023)

Correction: Galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling
por: Gedaj, Aleksandra, et al.
Publicado: (2023)

FGF1 Protects MCF-7 Cells against Taltobulin through Both the MEKs/ERKs and PI3K/AKT Signaling Pathway
por: Szymczyk, Jakub, et al.
Publicado: (2023)

FGF2 Dual Warhead Conjugate with Monomethyl Auristatin E and α-Amanitin Displays a Cytotoxic Effect towards Cancer Cells Overproducing FGF Receptor 1
por: Świderska, Karolina Weronika, et al.
Publicado: (2018)

Crosstalk between p38 and Erk 1/2 in Downregulation of FGF1-Induced Signaling
por: Zakrzewska, Malgorzata, et al.
Publicado: (2019)

Stable Fibroblast Growth Factor 2 Dimers with High Pro-Survival and Mitogenic Potential
por: Nawrocka, Daria, et al.
Publicado: (2020)

Generation of high-affinity, internalizing anti-FGFR2 single-chain variable antibody fragment fused with Fc for targeting gastrointestinal cancers
por: Borek, Aleksandra, et al.
Publicado: (2018)

The Significance of Cell Surface N-Glycosylation for Internalization and Potency of Cytotoxic Conjugates Targeting Receptor Tyrosine Kinases
por: Poźniak, Marta, et al.
Publicado: (2022)

FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1
por: Jendryczko, Karolina, et al.
Publicado: (2020)

Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
por: Jendryczko, Karolina, et al.
Publicado: (2021)

Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1)
por: Krzyscik, Mateusz Adam, et al.
Publicado: (2020)

FGF1-gold nanoparticle conjugates targeting FGFR efficiently decrease cell viability upon NIR irradiation
por: Szlachcic, Anna, et al.
Publicado: (2012)

Drug Conjugation via Maleimide–Thiol Chemistry Does Not Affect Targeting Properties of Cysteine-Containing Anti-FGFR1 Peptibodies
por: Jendryczko, Karolina, et al.
Publicado: (2022)

FGF1 Fusions with the Fc Fragment of IgG1 for the Assembly of GFPpolygons-Mediated Multivalent Complexes Recognizing FGFRs
por: Poźniak, Marta, et al.
Publicado: (2021)

Cytotoxic Conjugates of Fibroblast Growth Factor 2 (FGF2) with Monomethyl Auristatin E for Effective Killing of Cells Expressing FGF Receptors
por: Krzyscik, Mateusz Adam, et al.
Publicado: (2017)

Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity
por: Chudzian, Julia, et al.
Publicado: (2018)

Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy
por: Szlachcic, Anna, et al.
Publicado: (2016)

Identification of a peptide antagonist of the FGF1–FGFR1 signaling axis by phage display selection
por: Lipok, Magdalena, et al.
Publicado: (2019)

Roles of the FGF-FGFR Signaling System in Cancer Development and Inflammation
por: Wiedlocha, Antoni, et al.
Publicado: (2021)

Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy
por: Jurek, Przemysław M, et al.
Publicado: (2017)

Identification of new FGF1 binding partners—Implications for its intracellular function
por: Bober, Joanna, et al.
Publicado: (2016)

Correction: Serwotka-Suszczak, A. M. et al. A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells. Int. J. Mol. Sci. 2017, 18, 401
por: Serwotka-Suszczak, Anna M., et al.
Publicado: (2018)

A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells
por: Serwotka-Suszczak, Anna M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kk501tbhbcpbsi6qs6f20f7174